Decibel Therapeutics DBTX

$ 4.91 0.0%

Quarterly report 2023-Q2
added 08-11-2023

Decibel Therapeutics Income Statement 2011-2024 | DBTX

Annual Income Statement Decibel Therapeutics

	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	102 M	93.5 M	-	-	-	-	-	-	-	-	-	-
Shares	25 M	21.7 M	-	-	-	-	-	-	-	-	-	-
Historical Prices	4.09	4.3	-	-	-	-	-	-	-	-	-	-
Net Income	-63 M	-51.8 M	-39.3 M	-42.7 M	-36.2 M	-	-	-	-	-	-	-
Revenue	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-64 M	-50.2 M	-39.6 M	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-62.5 M	-48.8 M	-39.6 M	-42.3 M	-36.4 M	-	-	-	-	-	-	-
Operating Expenses	64 M	50.2 M	39.6 M	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	23.6 M	20.4 M	14.2 M	14.7 M	11.7 M	-	-	-	-	-	-	-

All numbers in USD currency

Quarterly Income Statement Decibel Therapeutics

	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	25 M	25 M	25 M	25 M	25 M	25 M	25 M	24.9 M	24.9 M	12.1 M	521 K	488 K	469 K	449 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-18.1 M	-13.3 M	-	-16 M	-17 M	-14 M	-	-16.4 M	-11.7 M	-10.9 M	-	-7.11 M	-7.81 M	-11.5 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-19 M	-14.1 M	-	-16.3 M	-17.1 M	-14 M	-	-14.7 M	-11.7 M	-10.9 M	-	-7.09 M	-7.85 M	-11.6 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-13.8 M	-	-15.3 M	-16.4 M	-13.7 M	-	-13.6 M	-11 M	-10.5 M	-	-5.79 M	-6.95 M	-11.1 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	19 M	14.1 M	-	16.3 M	17.1 M	14 M	-	14.7 M	11.7 M	10.9 M	-	7.09 M	7.85 M	11.6 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	6.21 M	6.19 M	-	6.32 M	5.86 M	6.55 M	-	5.68 M	4.9 M	4.88 M	-	2.4 M	2.56 M	4.18 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency